97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

9 trials found

diseases per page:

Showing 1 to 9 of 9 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05118919 (ClinicalTrials.gov)	February 9, 2022	26/10/2021	A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis	A Randomised Placebo-controlled Safety Study of LactobacillusReuteri BGP-014 in Patients With Mild t ...	Ulcerative Colitis	Biological: BGP-014;Biological: Placebo	BioGaia Pharma AB	NULL	Recruiting	18 Years	N/A	All	50	Phase 1/Phase 2	Sweden
2	EUCTR2019-004578-25-SE (EUCTR)	09/07/2021	27/12/2019	A clinical study in patients with mild to moderate ulcerative colitis to test the tolerability of La ...	A randomised placebo-controlled safety study of Lactobacillusreuteri BGP-014 in patients with active ...	Mild to moderate ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] ...	Product Name: BGP-014 Capsules Product Code: BGP-014 INN or Proposed INN: Lactobacillusreuteri Other des ...	BioGaia Pharma AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 1;Phase 2	Sweden
3	NCT04102852 (ClinicalTrials.gov)	September 30, 2019	17/9/2019	Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients	The Role of LactobacillusRhamnosus GG (ATCC 53103) in the Modulation of the Inflammatory Process in ...	Ulcerative Colitis Chronic Mild;Ulcerative Colitis Chronic Moderate	Dietary Supplement: Lactobacillus rhamnosus GG ATCC 53103	San Giovanni Addolorata Hospital	Onlus S. Andrea	Recruiting	18 Years	65 Years	All	80	Phase 1/Phase 2	Italy
4	NCT03798210 (ClinicalTrials.gov)	January 1, 2017	7/1/2019	Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis	The Effect of Lactobacillus Reuteri ATCC PTA 4659 in Patients With Ulcerative Colitis	Ulcerative Colitis Flare	Dietary Supplement: Lactobacillus reuteri;Dietary Supplement: Placebo	Uppsala University	NULL	Recruiting	18 Years	80 Years	All	40	Phase 2	Sweden
5	NCT03136419 (ClinicalTrials.gov)	October 31, 2016	5/4/2017	Microbiota and Immune microEnvironment in Pouchitis	Microbiota and Immune microEnvironment in Pouchitis: Randomized Controlled Trial Oral Administration ...	Pouchitis;Ulcerative Colitis;Ileal Pouch	Dietary Supplement: Lactobacillus casei DG;Dietary Supplement: Placebo	University of Padova	NULL	Recruiting	18 Years	100 Years	All	32	N/A	Italy
6	NCT00895336 (ClinicalTrials.gov)	March 2011	27/4/2009	Lactobacillus GG in Pediatric Ulcerative Colitis (UC)	An Open Label Pilot Study of Lactobacillus GG in Pediatric Ulcerative Colitis	Ulcerative Colitis	Biological: Lactobacillus GG	Children's Hospital Medical Center, Cincinnati	NULL	Withdrawn	5 Years	18 Years	All	0	Phase 2	United States
7	NCT00268164 (ClinicalTrials.gov)	June 2004	21/12/2005	LactobacillusAcidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcera ...	LactobacillusAcidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcera ...	Ulcerative Colitis	Drug: lactobacilus acidophilus & bifidobacterium animalis/lactis	Hvidovre University Hospital	Chr Hansen A/S	Terminated	18 Years	N/A	Both	48	Phase 2	Denmark
8	NCT00374725 (ClinicalTrials.gov)	February 2003	7/9/2006	Treatment of Ulcerative Colitis With a Combination of LactobacillusRhamnosus and LactobacillusAcidop ...	Treatment of Ulcerative Colitis With a Combination of LactobacillusRhamnosus and LactobacillusAcidop ...	Ulcerative Colitis	Behavioral: Administration of probiotic (L. rhamnosus and L. acidophilus)	Odense University Hospital	University of Southern Denmark;Crohn's and Colitis Foundation	Completed	18 Years	N/A	Both	130	N/A	Denmark
9	NCT00510978 (ClinicalTrials.gov)	January 2002	2/8/2007	Probiotics in GastroIntestinal Disorders	One Year, Randomised, Double Blind, Placebo Controlled Trial of Probiotics, Bifidobacterium Infantis ...	Ulcerative Colitis;Crohn's Disease	Biological: Bifidobacterium infantis 35624;Biological: Lactobacillussalivarius UCC118;Biological: Plac ...	University College Cork	European Commission	Active, not recruiting	N/A	75 Years	Both	360	Phase 2/Phase 3	Ireland

First Previous1Next Last